These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11736717)

  • 21. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis.
    Lo GH; Yu HC; Chan YC; Chen WC; Hsu PI; Lin CK; Lai KH
    Gastrointest Endosc; 2005 Sep; 62(3):350-6. PubMed ID: 16111950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.
    Taha AS; Dahill S; Nakshabendi I; Lee FD; Sturrock RD; Russell RI
    Gut; 1993 Sep; 34(9):1162-6. PubMed ID: 8406146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs.
    Taha AS; Sturrock RD; Russell RI
    Am J Gastroenterol; 1992 Dec; 87(12):1732-5. PubMed ID: 1360191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study.
    Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O
    J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
    Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis.
    Tanaka E; Kamitsuji S; Inoue E; Yamada T; Nakajima A; Takeuchi E; Yanagisawa A; Misaka R; Shigemoto M; Yamashita K; Imamura T; Hara M; Tomatsu T; Saito T; Lauren G; Triadafilopoulos G; Kamatani N; Singh G; Yamanaka H
    Mod Rheumatol; 2007; 17(3):228-34. PubMed ID: 17564779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
    Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
    Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Helicobacter pylori and gastroduodenal lesions in 547 symptomatic young adults].
    Rudelli A; Vialette G; Brazier F; Seurat PL; Capron D; Dupas JL
    Gastroenterol Clin Biol; 1996; 20(4):367-73. PubMed ID: 8758504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
    Lai KC; Lau CS; Ip WY; Wong BC; Hui WM; Hu WH; Wong RW; Lam SK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):799-805. PubMed ID: 12641502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of peptic ulcer perforation in Korea.
    Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
    World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics.
    Chu KM; Kwok KF; Law S; Wong KH
    World J Gastroenterol; 2005 Jun; 11(23):3518-22. PubMed ID: 15962366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
    Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
    Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
    Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori-positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes.
    Tam YH; Lee KH; To KF; Chan KW; Cheung ST
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):299-305. PubMed ID: 19274785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer].
    Ben Ammar A; Cheikh I; Ouerghi H; Chaabouni H; Kchaou M; Ben Mami N
    Tunis Med; 2002 Oct; 80(10):599-604. PubMed ID: 12632753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P; Teglbjaerg PS;
    Am J Gastroenterol; 2001 May; 96(5):1409-16. PubMed ID: 11374675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.